Regen BioPharma, Inc.
RGBP
$0.055
$0.000.00%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -99.42% | 8,728.57% | -10.95% | 205.90% | 136.33% |
Total Receivables | -- | 18.76% | -49.81% | -90.66% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 543.00% | 333.33% | -69.77% | -73.82% | -67.64% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 22.06% | 143.45% | -33.19% | -25.95% | -61.06% |
|
|||||
Total Current Assets | 22.06% | 143.45% | -33.19% | -25.95% | -61.06% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -49.77% | -40.32% | -65.37% | -61.48% | -36.74% |
|
|||||
Total Accounts Payable | 0.00% | 0.00% | -12.35% | 42.58% | 3.13% |
Total Accrued Expenses | 1.21% | 1.99% | 1.79% | 3.03% | -17.84% |
Short-term Debt | 204.86% | 115.54% | -50.64% | 2,852.94% | 5,588.24% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -1.96% | -1.96% | -1.96% | 0.00% | -59.92% |
Total Finance Division Other Current Liabilities | -4.77% | -4.15% | -4.11% | -5.17% | -42.78% |
Total Other Current Liabilities | -4.77% | -4.15% | -4.11% | -5.17% | -42.78% |
Total Current Liabilities | 1.20% | 0.26% | -3.06% | -0.98% | -38.24% |
|
|||||
Total Current Liabilities | 1.20% | 0.26% | -3.06% | -0.98% | -38.24% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 204.86% | 115.54% | -50.64% | 2,852.94% | 5,588.24% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -1.58% | 0.26% | -0.37% | 1.93% | -36.50% |
|
|||||
Common Stock & APIC | 5.30% | 5.55% | 4.52% | 3.75% | 14.23% |
Retained Earnings | -4.39% | -4.77% | -4.64% | -4.30% | 5.53% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -1.78% | -2.56% | -4.99% | -5.89% | 36.87% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -100.00% | -100.00% |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -100.00% | -100.00% |
|
|||||
Total Common Equity | -1.78% | -2.56% | -4.99% | -5.89% | 36.87% |
Total Preferred Equity | -- | -- | -- | -100.00% | -100.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.76% | -2.56% | -4.99% | -7.30% | 36.49% |
|